1. Introduction {#sec1-molecules-21-01648}
===============

Metabolomics, a new field in systems biology, represents an emerging and powerful discipline concerned with the comprehensive analysis of small molecules (\<1 kDa); it provides a powerful approach for the discovery of biomarkers in biological systems \[[@B1-molecules-21-01648],[@B2-molecules-21-01648],[@B3-molecules-21-01648],[@B4-molecules-21-01648]\]. Metabolomics provides a quantitative analysis of all low-molecular-mass metabolites and lends insight into the relationship between metabolites and changes in physiology/pathophysiology status in biochemical networks and pathways by combining a range of different analytical technologies and calculation methods \[[@B5-molecules-21-01648],[@B6-molecules-21-01648],[@B7-molecules-21-01648]\]. These techniques have recently demonstrated significant potential in many fields, such as toxicology \[[@B8-molecules-21-01648]\], nutrition \[[@B9-molecules-21-01648]\], environmental stress \[[@B10-molecules-21-01648]\], global effects of genetic manipulation, disease diagnosis, drug mechanism and development, natural product discovery, and comparison of different growth stages \[[@B11-molecules-21-01648],[@B12-molecules-21-01648]\]. Additionally, metabolomics has been used in food science to assess food quality, food safety, food microbiology, and food processing \[[@B13-molecules-21-01648],[@B14-molecules-21-01648],[@B15-molecules-21-01648]\]. Furthermore, the global metabolite profile now enables much more detailed studies of noninvasive biomarkers that can detect different growth stages in plants.

Plant studies using metabolomics techniques aim for the simultaneous detection of all metabolites in plant tissues. Metabolomics detection technology includes nuclear magnetic resonance (NMR) spectroscopy, liquid chromatography-mass spectrometry (LC--MS) \[[@B16-molecules-21-01648]\], and gas chromatography--mass spectrometry (GC--MS). Among these, GC--MS is mainly suited for compound classes appearing mainly in primary metabolic pathways, such as amino acids, fatty acids, carbohydrates, and organic acids \[[@B17-molecules-21-01648]\]. LC--MS is more suitable for assessing the overall biochemical richness of plants. This technique analytically covers the large (semipolar) group of plant secondary metabolites including alkaloids, saponins, phenolic acids, phenylpropanoids, flavonoids, glucosinolates, polyamines, and their derivatives \[[@B18-molecules-21-01648],[@B19-molecules-21-01648]\]. Therefore, LC--MS is preferred over the other techniques in the study of numerous structure databases \[[@B20-molecules-21-01648]\]. At present, LC--MS has become one of the frequently used techniques in metabolomics studies because of its high sensitivity and reproducibility.

The Chinese water chestnut (CWC, *Eleocharis tuberosa*) is one of the most popular hydrophytic vegetables in China because of its unique taste \[[@B21-molecules-21-01648]\]. However, it is usually peeled before being eaten, and fresh-cut CWC turns yellow after being peeled, reducing its shelf life and its commercial value. Recent studies have shown that CWC etiolation is linked to the presence of eriodictyol and naringenin \[[@B21-molecules-21-01648]\]. In addition, most researches have shown that phenylalanine ammonia-lyase (PAL) was present in fresh-cut CWC tissue. With the extension of storage time, the activity of PAL increases and the etiolation of CWC also increases. Therefore, the metabolic pathways of eriodictyol and naringenin are believed to be associated with PAL activity \[[@B22-molecules-21-01648]\]. PAL is a critical and rate-limiting enzyme in the phenylpropanoid metabolic pathway, a pathway that also contains eriodictyol and naringenin \[[@B23-molecules-21-01648],[@B24-molecules-21-01648],[@B25-molecules-21-01648],[@B26-molecules-21-01648]\]. It is therefore probable that the etiolation process of fresh-cut CWC is related to the functioning of the phenylpropanoid metabolic pathway. However, there may be a variety of specific metabolic pathways related to yellowing, and few prior studies have investigated these pathways fully.

The synthesis of flavonoids begins with the shikimic acid metabolic pathway, which generates phenylalanine. This molecule then enters the phenylpropanoid metabolic pathway, and then, through the common enzyme chalcone synthase, enters the flavonoid synthesis pathway, which generates the various flavonoids through different branches \[[@B27-molecules-21-01648],[@B28-molecules-21-01648]\]. Though the use of metabolomics to research flavonoids is relatively uncommon, both naringenin and eriodictyol are considered flavonoids, and the molecular weight of most flavonoids is below 1 kDa; therefore, the metabolites of the etiolation process are suitable for studying with metabolomics techniques. Literature about the process of involving metabolomics in the research of flavonoids is very common, especially in herbal aspects \[[@B29-molecules-21-01648],[@B30-molecules-21-01648]\]. In terms of fruit and vegetables, the glycosides of luteolin and apigenin as well as quercetin conjugates were identified from *Phoenix dactylifera* (date palm) fruits using UPLC/PDA/ESI-TOF-MS methods \[[@B31-molecules-21-01648],[@B32-molecules-21-01648]\]. Flavonoids in blueberry extracts were analyzed through HPLC-ESI-MS/MS, which identified that anthocyanins and flavonoid alcohols are the main components \[[@B32-molecules-21-01648]\]. Therefore, there is precedence for identifying the characteristic flavonoids and metabolic pathways from plants.

In order to clarify the mechanism of fresh-cut CWC etiolation and yellowing, as well as to evaluate the safety of the etiolation metabolite, we sought to discover the metabolic pathways of the molecules responsible for etiolation. In this study, we used the LC--MS method combined with additional analytical technologies and calculation methods (principal component analysis (PCA), partial least squares-discriminant analysis (PLS-DA), orthogonal projection to latent structures-discriminant analysis (OPLS-DA)) to analyze the metabolic pathways of etiolation in fresh-cut CWC.

2. Results and Discussion {#sec2-molecules-21-01648}
=========================

2.1. LC--MS Analysis of Metabolic Patterns {#sec2dot1-molecules-21-01648}
------------------------------------------

In this study, five time points from the yellowing process of CWC were studied using an LC--MS metabolomics approach. For the analysis, we compared 0 day (see Methods) with 2 days (0--2), 2 days with 3 days (2--3), 3 days with 4 days (3--4), and 4 days with 5 days (4--5) for screening and identification of the metabolites. According to peak height data, we detected 1046 positive-ion (ESI+) peaks and 1962 negative-ion (ESI−) peaks by Mass Profiler using the same acquiring method of 0.5--15 min of retention time, and then the normalized data were fed to SIMCA-P. The parameters (R^2^X, R^2^Y, and Q^2^Y) obtained from SIMCA-P indicated that the model was able to distinguish between each of the yellowing time points in both ion modes.

To further evaluate the capability of the LC--MS-based metabolomics approach to distinguish between all of the time points, multivariate data analyses (PCA, PLS-DA, OPLS-DA) were performed. In the PCA analysis, we identified five principal components in positive mode (R^2^X = 0.464, Q^2^ = 0.124) ([Figure 1](#molecules-21-01648-f001){ref-type="fig"}). For this nonsupervisory PCA model, the R^2^X parameter-which describes the rate of the model-can be used to determine the model's quality. Generally, a model is reliable when R^2^X \> 0.4 \[[@B33-molecules-21-01648]\]. Thus, the current PCA model was suited to explain the metabolic differences between each group. Every point in [Figure 2](#molecules-21-01648-f002){ref-type="fig"} represents a sample with the fresh-cut CWC; from the PCA analysis it can be visually seen that there is a significant difference between each pair of time points, except for between 3 days and 4 days. Furthermore, the between-group differences were significantly greater than the intergroup differences, indicating that substantial biochemical perturbation occurred in all groups. PCA as an unsupervised analysis method, responsive to the primitive state of the data, can be used to observe the relationship between each group, but it cannot account for intergroup errors or eliminate the random error unrelated to this research. In order to obtain information on which metabolites were the cause of the differences, we conducted PLS-DA and OPLS-DA analyses for each pair of time points.

The supervised PLS-DA analysis revealed greater differences in the metabolic signature between each pair of time points, focusing on intergroup differences and minimizing between-group differences to better grasp the overall characteristics and variation of the data. For each pair of time points studied, this analysis was performed in both the positive mode and negative mode. Results for each pair are as follows ([Figure 2](#molecules-21-01648-f002){ref-type="fig"}): in positive mode, groups 0--2 obtained one principal component (R^2^X = 0.253, R^2^Y = 0.97, Q^2^ = 0.845); groups 2--3, one principal component was obtained (R^2^X = 0.328, R^2^Y = 0.923, Q^2^ = 0.68); groups 3--4 obtained one principal component (R^2^X = 0.179, R^2^Y = 0.897, Q^2^ = 0.588); groups 4--5, one principal component was obtained (R^2^X = 0.198, R^2^Y = 0.867, Q^2^ = 0.514); in negative mode, groups 0--2 obtained one principal component (R^2^X = 0.278, R^2^Y = 0.945, Q^2^ = 0.829); 2--3, one principal component was obtained (R^2^X = 0.298, R^2^Y = 0.913, Q^2^ = 0.787); groups 3--4 obtained two principal components (R^2^X = 0.321, R^2^Y = 0.991, Q^2^ = 0.806); groups 4--5, one principal component was obtained (R^2^X = 0.259, R^2^Y = 0.879, Q^2^ = 0.712). The model parameters (R^2^X and Q^2^) indicate that the current PLS-DA models were reliable and suitable for interpretation between each pair of time points of metabolic differences and finding the differences. Meanwhile, the left of the arrange experiments were randomly generated depending on whether the value of R^2^ and Q^2^ was less than the original value from the right. This indicates that the predictive power of the original model is greater than any randomized *y* variables, thus, the model is effective and it can continue to be applied to the different metabolites.

Typically, OPLS-DA analysis is conducted to search for the different components that lead to the maximum differences between two samples. In order to further obtain the metabolic differences, this study applied an OPLS-DA approach; separating samples into two blocks. As can be seen from [Figure 3](#molecules-21-01648-f003){ref-type="fig"}, compared with PCA analysis, each group received the highest degree of separation, which is useful to determine the metabolic differences.

2.2. Identification of Metabolites {#sec2dot2-molecules-21-01648}
----------------------------------

All metabolites from each total ion chromatogram were extracted and aligned using Mass Profiler software. All information, including retention time, peak intensity, and exact mass, was supplied by the LC-Q/TOF-MS platform. The metabolites (VIP (variable importance in the projection) \> 1) were analyzed by *t*-test, and metabolites with a *p*-value \< 0.05 were identified as metabolic differences.

### 2.2.1. Identification of Metabolites in 0--2 Days {#sec2dot2dot1-molecules-21-01648}

Comparing the samples of 0 day with 2 days, the main metabolite differences are shown in [Table 1](#molecules-21-01648-t001){ref-type="table"} and [Table 2](#molecules-21-01648-t002){ref-type="table"}. In the positive mode, 5′-deoxy-5′-(methylthio) adenosine, ferulic acid, and linolenic acid showed significant increases, while *N*-palmitoyl threonine and stearidonic acid decreased. Among these, the linolenic acid at 2 days compared with 0 day increased by about 19 times. In the negative mode, salicylaldehyde, salicylic acid, naringenin, eriodictyol, pentahydroxyflavanone, apigenin-glucuronide, and luteolin 5-methyl ether 7-glucoside were increased significantly. The naringenin has increased by about 4820 times and the eriodictyol was increased by about 700 times, while the PE (phosphatidyl ethanolamine) (18:3), PE (18:1), and quercetin 3-*O*-(6″-malonyl-glucoside) 7-*O*-glucoside at 2 days compared with 0 day were decreased by 600 times. Thus, the metabolites between 0 day and 2 days have significant differences, and these metabolites were related to the pathways of fresh-cut CWC yellowing.

### 2.2.2. Identification of Metabolites in 2--3 Days {#sec2dot2dot2-molecules-21-01648}

Comparing the samples of 2 days with 3 days, the main metabolite differences are shown in [Table 3](#molecules-21-01648-t003){ref-type="table"} and [Table 4](#molecules-21-01648-t004){ref-type="table"}. In the positive mode, cyanidin 3-*O*-(6-*O*-malonyl-β-[d]{.smallcaps}-glucoside) and dihydroxy-6,7,4′,5′-tetramethoxyflavone increased significantly, while aconitic acid and MG (18:2) decreased. In the negative mode, phenylacetic acid, vanillic acid, quinic acid, quercetin and its derivatives, dihydroxy-dimethoxy-methylenedioxy, the derivatives of naringenin, malvidin, and luteolin were increased significantly, all of them showing an average increase of about 280 times. In contrast, ascorbic acid and arginine at 3 days, compared with 2 days, were decreased by 4 times. The major differences were identified to further explore the pathway of CWC yellowing.

### 2.2.3. Identification of Metabolites in 3--4 Days {#sec2dot2dot3-molecules-21-01648}

Comparing the samples of 3 days with 4 days, the main metabolite differences are shown in [Table 5](#molecules-21-01648-t005){ref-type="table"} and [Table 6](#molecules-21-01648-t006){ref-type="table"}. Overall, the metabolic differences between 3 days and 4 days were few. In the positive mode, dihydroxy-7,2′-dimethoxyflavanone at 4 days compared with 3 days was increased by about 3.5 times. On the other hand, trihydroxy-3-methoxyflavone decreased by about 12 times. From the negative mode, kolaflavanone, eriodictyol, the derivative of naringenin, cyanidin, and myricetin were increased. In contrast, linolenic acid and phenylacetic acid at 4 days, compared with 3 days were decreased.

### 2.2.4. Identification of Metabolites in 4--5 Days {#sec2dot2dot4-molecules-21-01648}

Comparing the samples of 4 days with 5 days, the main metabolite differences are shown in [Table 7](#molecules-21-01648-t007){ref-type="table"} and [Table 8](#molecules-21-01648-t008){ref-type="table"}. In the positive mode, dehydrophytosphingosine at 5 days, compared with 4 days, increased by about 5400 times. From the negative mode, naringenin-4'-*O*-β-[d]{.smallcaps}-glucuronide changes significantly. At 5 days, compared with the 4 days, it fell by about 110 times; other metabolic changes were small.

2.3. Biological Pathway and Function Analysis {#sec2dot3-molecules-21-01648}
---------------------------------------------

Using pattern recognition analysis on the metabolites, we were able to achieve a clear separation between each pair of time points. To identify the pathways involved in fresh-cut CWC etiolation, previously identified metabolites were analyzed using MetPA (Metabolomic Pathway Analysis) software. MetPA is a web-based tool that derives much of its power from the KEGG metabolic pathways database. In metabolic networks, changes in more "important" positions result in a more substantial effects on the pathway compared to changes occurring in marginal or relatively isolated positions. In our analysis, we identified several pathways that appear to be involved in etiolation, including the glycolysis pathway, fatty acid metabolic pathway, citrate cycle pathway, and flavonoid biosynthesis pathway. The green parts in [Figure 4](#molecules-21-01648-f004){ref-type="fig"} represent the differences we have detected. In the glycolysis pathway, the α-[d]{.smallcaps}-glucose is converted to α-[d]{.smallcaps}-glucose-6p and then further transformed into glyceraldehyde-3P, while the α-[d]{.smallcaps}-glucose-6p is converted to histidine; glyceraldehyde-3P and glycerate-1,3P2 are convert to each other, and at the same time converted to 2-*C*-methyl-[d]{.smallcaps}-4-erythritol-4P. Glycerate-3P and phosphoenol-pyruvate are convert to each other and generate phosphoserine. Pyruvate is created from phosphoenol-pyruvate, and converts to octanoate (8:0), triggered the citrate cycle pathway. Furthermore, pyruvic, leucine, and [l]{.smallcaps}-alanine interactions in the flavonoid biosynthesis pathway have a certain effect.

The major substance that causes the fresh-cut CWC yellowing are naringenin and eriodictyol, both found in the flavonoid biosynthesis pathway. Therefore, the flavonoid biosynthesis pathway is the most important pathway for CWC yellowing. As we can see from [Figure 5](#molecules-21-01648-f005){ref-type="fig"}, phenylalanine is converted to p-coumaroyl-CoA, followed by conversion to naringenin chalcone, to naringenin, and then naringenin enters different pathways. Firstly, it can transform into apigenin and its derivatives; secondly, it can produce eriodictyol and its derivatives; and thirdly it can produce dihydrokaempferol, quercetin, and myricetin. From here, eriodictyol can be further transformed to luteolin, cyanidin, dihydroquercetin, dihydrotricetin, and others. According to the metabolism pathway, quercetin, myricetin, apigenin, luteolin, and other substances were also yellowing substances. Therefore, the yellowing of fresh-cut CWC is caused by several yellow substances, and our study indicated that the flavonoid biosynthetic pathway is the main mechanism for fresh-cut CWC yellowing. Detailed construction of the yellowing metabolism pathway is shown in [Figure 5](#molecules-21-01648-f005){ref-type="fig"}.

3. Materials and Methods {#sec3-molecules-21-01648}
========================

3.1. Chemicals, Reagents and Materials {#sec3dot1-molecules-21-01648}
--------------------------------------

Acetonitrile (LC/MS grade) and methanol (HPLC grade) were purchased from Merck (Damstadt, Gemany). Formic acid was purchased from CNW (Düsseldorf, Gemany). Leucine-enkephalin was obtained from Sigma Company (San Francisco, CA, USA). Distilled water was purchased from Watsons (Hong Kong, China). NaClO were purchased from "Xiya" Company (Chengdu, China).

Fresh CWCs were purchased in Haikou, China and stored in the laboratory at 17 °C. Fruits without physical damage or diseases and with uniform size were selected for analysis. CWCs were treated as reported by You \[[@B34-molecules-21-01648]\] and Peng \[[@B35-molecules-21-01648]\]. Fresh CWCs (100 kg) were washed, peeled using a sharp, stainless steel knife, and chopped into small, thick slices. The slices were then disinfected with 0.1% NaClO for 15 min before airing. The CWCs were packed with plastic packaging machines and preserved at 17 °C for 5 days.

To assess the primary metabolites as the CWCs turn yellow, CWCs were randomly selected from five different yellowing stages ([Figure 5](#molecules-21-01648-f005){ref-type="fig"}): one hour post-cutting (0 day), two days post-cutting (2 days), three days post-cutting (3 days), four days post-cutting (4 days), and five days post-cutting (5 days). Slices taken from the yellowed surface were then used as samples. Since the sample between 0 day and 1 d showed little difference, the sample of 1 d was removed from further analyses. Six samples from each of the five time stages (0.5 g each) were transferred to a 1.5 mL centrifuge tube, mixed with 1 mL solvent (MeOH/H~2~O, 7:3 *v*/*v*) by smashing for 1 min, extracted by ultrasonication for 10 min, and then separated by centrifugation at 12,000 rpm at 4 °C for 15 min. Finally, 100 μL aliquots of the supernatant were transferred to autosampler vials.

3.2. Metabolic Profiling and Data Analysis {#sec3dot2-molecules-21-01648}
------------------------------------------

Chromatographic analysis was performed on an Agilent C18 column (Agilent, 100 mm × 2.1 mm, 1.8 μm) using an Agilent LC system (Agilent, 1290 Infinity LC, 6530 UHD, Palo Alto, CA, USA). The column temperature was maintained at 40 °C and eluted at a flow rate of 0.4 mL/min. The mobile phase consisted of a linear gradient system of (A) 0.1% formic acid in water and (B) 0.1% formic acid in acetonitrile. The gradient elution process: 0--3 min, 20%--50% B; 3--13 min, 50%--95% B; 13--15 min, 95% B. The injection volume was 4 μL and the autosampler temperature was 4 °C.

The eluent was introduced into the mass spectrometer (Agilent 6530 Accurate-Mass Q-TOF/MS). The MS system was operated using positive-ion (ESI+) and negative-ion (ESI−) modes. Conditions of positive-ion analysis were as follows: nitrogen was used as the nebulizing gas; the cone gas flow was set at 50 L/h, and the desolvation gas flow was set at 600 L/h. The capillary voltage was 4.0 kV, the sampling cone voltage was 35.0 kV, the source temperature was 100 °C, the desolvation temperature was 350 °C, and the extraction cone voltage was 4.0 V. In negative-ion mode, the cone gas flow was set at 50 L/h and the desolvation gas flow was set at 700 L/h. The capillary voltage was 3.5 kV, the sampling cone voltage was 50 kV, the source temperature was 100 °C, the desolvation temperature was 300 °C, and the extraction cone voltage was 4.0 V. The scan time was set to 0.03 s with a 0.02 s interscan time. Data were collected from 50 to 1000 *m*/*z*. For accurate and repeatable mass acquisition, a lock-mass of leucine-enkephalin was used via a lock spray interface monitor for positive-ion mode (\[M + H\]^+^ = 556.2771 Da) and negative-ion mode (\[M − H\]^−^ = 554.2615 Da) to ensure accuracy during the MS analysis.

All data were processed using Mass Profiler in the MassHunter software platform (Agilent) for LC/MS data preprocessing, followed by manual postediting in Microsoft Excel. We removed impurity peaks due to column bleeding and sample preparation. The intensity of each ion was normalized with respect to the total ion count to generate a data matrix that consisted of the rt_mass (retention time_mass), the quantity of observe, and the normalized peak. After that, the multivariate data matrix was introduced into SIMCA-P 13.0 software (Umetrics, Umeå, Sweden) for PCA. PCA data were visualized by plotting the PC scores, with each point representing one rt_mass pair. Thus, the loading plot gives an indication of the metabolites that most strongly influence the patterns in the score plot. In order to further discriminate the metabolites and biomarkers, the data were analyzed using PLS-DA and OPLS-DA methods. Variables that significantly discriminated between groups were considered potential biomarkers and were assigned with *p*-values using a student's test (*t*-test); *p*-values less than 0.05 were considered statistically significant \[[@B36-molecules-21-01648]\]. The identities of specific metabolites were confirmed by comparison of their mass spectra and mass-to-charge ratio (*m*/*z*) with free online databases, including METLIN (<http://metlin.scripps.edu/>).

The construction, interaction, and pathway analyses of potential biomarkers were performed with MetaboAnalyst 2.0, with database sources, including METLIN and KEGG (<http://www.genome.jp/kegg/>), to help identify pathways that were most significantly altered.

4. Discussion {#sec4-molecules-21-01648}
=============

The yellowing of fresh-cut CWC is one of the leading causes of reduced shelf life and commercial value, and it is known to be enzymatically different from the browning of other vegetables and fruits \[[@B37-molecules-21-01648],[@B38-molecules-21-01648],[@B39-molecules-21-01648]\]. Despite attempts to reduce CWC yellowing \[[@B37-molecules-21-01648],[@B40-molecules-21-01648]\], we still lack methods to fundamentally inhibit etiolation, and the mechanism of yellowing remains unclear. The advent of the metabolomics field represents a paradigm shift in metabolic research, away from methods that focus on a limited number of single pathways and towards approaches that capture the entire complexity of metabolic networks \[[@B41-molecules-21-01648]\]. Emerging techniques in metabolomics provide a powerful platform for discovering novel biomarkers and biochemical pathways \[[@B42-molecules-21-01648]\]. This may allow us to develop techniques that inhibit CWC yellowing, potentially leading to future advances in inhibition of these pathways.

In this study, samples from different time points of CWC yellowing were analyzed by LC-Q/TOF-MS, coupled with multivariate data analyses; the major metabolic differences were obtained. All samples were successfully modeled, and we identified significant differences in PCA scores between each pair of time points. The pattern was verified as authentic by the PLS-DA analysis. Then, the difference between each pair of time points was analyzed by OPLS-DA combined with *t*-test, and the metabolites were obtained. It was found that metabolic differences include organic acids (such as salicylic acid, citric acid, ferulic acid, leucine, [l]{.smallcaps}-aspartic acid, lysine etc.) and flavonoids (like eriodictyol, naringenin, quercetin, myricetin, apigenin, luteolin etc.), while sucrose mainly existed in negative mode. Among those mentioned, two of the flavonoids were yellowing substances. The content changes of eriodictyol and naringenin is outstanding, which showed an upward trend that was proportional to the degree of fresh-cut CWC yellowing during the storage time. The change of myricetin showed a moderate upward trend during storage. In comparison with eriodictyol and naringenin, the change in apigenin and luteolin showed less of an upward trend and did not rise after that time, and the content of quercetin showed fluctuations in growth, which is currently under further investigation. It was demonstrated that the yellowing phenomenon of fresh-cut CWC was caused by a series of yellowing substances, mainly eriodictyol and naringenin, which is consistent with the study of Pan \[[@B21-molecules-21-01648]\]; the content of flavonoids that cause yellowing was proportional to the degree of fresh-cut CWC yellowing. Nowadays, flavonoids are known to be key antioxidant substances that have antiaging, disease resistance, antimicrobial, anti-inflammatory, and antitumor activities, and are becoming more and more abundant in modern life. This study aims to lay the foundation for the further study of fresh-cut CWC yellowing by investigating the substances causing the phenomenon \[[@B43-molecules-21-01648]\]. It was proved that yellowing substances of fresh-cut CWC were connected with the glycolysis pathway, fatty acid metabolism pathway, citrate cycle pathway, and flavonoid biosynthetic pathway by identifying metabolic differences combined with METLIN and KEGG data. Among the metabolites identified, organic acids began to accumulate in the initial stage of the fresh-cut CWC yellowing and were consumed as respiratory matrixes of the glycolysis pathway and citrate cycle pathway in their last stages. Organic acids also participate in respiration and metabolic processes of phenols, amino acids, esters, and flavonoids \[[@B44-molecules-21-01648]\], explaining that organic acids increased gradually at the early time points and descend gradually at the end.

The flavonoids causing the yellowing of fresh-cut CWC mainly derived from the flavonoid biosynthetic pathway. It was proved that phenylalanine was converted into *p*-coumaric-CoA in the first step, which consistent with the study of Burbulis \[[@B45-molecules-21-01648]\]. Naringenin, which is a significant checkpoint in the flavonoid biosynthetic pathway, is converted into the second key substance, eriodictyol, which was converted into dihydrokaempferol, then quercetin, and finally, myricetin. In the metabolic pathway, luteolin, apigenin and its derivatives, quercetin, and myricetin were also yellowing substances, in addition to naringenin and eriodictyol, which revealed that the yellowing is the result of the joint action of flavonoids, mainly naringenin and eriodictyol. This suggests that the etiolation molecules are a mixture of metabolites, but it is clear that the main substances are naringenin and eriodictyol. According to other research reports, in the tissue of grape and corn, 4-coumarin-CoA is generated by phenylalanine in the phenylpropanoid metabolic pathway, which is converted into naringenin chalcone, then naringenin, eriodictyol, and pentahydroxyflavanone were generated in the end \[[@B46-molecules-21-01648]\]; these reports are consistent with this study. The pathway of fresh-cut CWC yellowing is complex, and each pathway contains multiple metabolites; there are rare reports about the relationship between the intermediate products and their interaction mechanism that leads to yellow that it is a complex pathway. In the further work, an in vitro model will be set up to simulate the process of flesh-cut CWC yellowing to confirm the reliability of the metabolic pathways.

5. Conclusions {#sec5-molecules-21-01648}
==============

To the best of our knowledge, this is the first report of a metabolomics study of the etiolation of fresh-cut CWC. A rapid, reliable, and sensitive LC-Q/TOF-MS method was validated for qualitative analysis of the different stages of CWC yellowing. Metabolites from each time point could be distinguished from each other by this method, which demonstrates that a significant metabolic perturbation is occurring. These 3008 peaks (1046 peaks in positive mode and 1962 in negative mode) could be useful as biomarkers for the different stages of yellowing. Interestingly, the flavanoid metabolic pathway emerged as a key pathway in the etiolation of fresh-cut CWC. This study also identified eriodictyol, naringenin, and sucrose as important features in this process, verifying the results of our previous study \[[@B21-molecules-21-01648]\]. This investigation is a good starting point for providing a better theoretical understanding of how to efficiently inhibit the yellowing of CWC. However, further studies are needed for a deeper understanding of the metabolic pathways and enzymes that are associated with CWC yellowing.
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molecules-21-01648-t001_Table 1

###### 

The main identification obtained between 0 day and 2 days in ESI+ (*p* \< 0.05).

  VIP     RT (min)   Mass       Name                                       *T*-Test   Fold (2/0) \*
  ------- ---------- ---------- ------------------------------------------ ---------- ---------------
  1.248   13.14      278.2252   Linolenic Acid                             0.001      +6.567
  1.408   4.91       194.0582   ferulic acid                               0.000      +4.237
  1.779   4.06       297.09     5′-Deoxy-5′-(methylthio)adenosine          0.001      +4.040
  1.479   6.60       548.1175   Chrysoeriol 7-*O*-(6″-malonyl-glucoside)   0.000      +2.683
  1.204   10.19      357.2886   *N*-palmitoyl threonine                    0.009      −2.457
  1.843   8.06       276.2095   Stearidonic Acid                           0.006      −2.086
  1.137   4.33       137.0477   Anthranilic acid                           0.000      −1.716
  1.181   4.39       264.137    Abscisic Acid                              0.038      −1.408
  1.668   0.82       115.064    Proline                                    0.007      +0.275

\* 0 day and 2 days is the logarithm of the ratio of the value of value (base 2), "+" means 2 days increase relative to 0 day, "−" means decrease. VIP: Variable Importance in the Projection; RT: retention time.

molecules-21-01648-t002_Table 2

###### 

The main identification obtained between 0 day and 2 days in ESI− (*p* \< 0.05).

  VIP     RT (min)   Mass       Name                                                         *T*-Test   Fold (2/0) \*
  ------- ---------- ---------- ------------------------------------------------------------ ---------- ---------------
  1.612   7.57       272.0694   Naringenin                                                   0.001      +28.844
  1.778   5.82       288.0642   Eriodictyol                                                  0.000      +26.056
  1.773   6.11       462.1179   Luteolin 5-methyl ether 7-glucoside                          0.000      +24.638
  1.325   11.24      479.3027   PE (18:1)                                                    0.017      −24.315
  1.759   13.13      278.2251   Linolenic Acid                                               0.000      24.309
  1.153   3.47       712.1513   Quercetin 3-*O*-(6″-malonyl-glucoside) 7-*O*-glucoside       0.046      −24.296
  1.624   4.87       304.0593   Pentahydroxyflavanone                                        0.001      +24.082
  1.459   4.97       450.1182   Eriodictyol 5-*O*-glucoside                                  0.006      +23.416
  1.398   10.03      475.271    PE (18:3)                                                    0.010      −23.115
  1.482   6.57       446.0862   Apigenin-glucuronide                                         0.005      +22.622
  1.459   10.68      477.2872   PE (18:2)                                                    0.006      −5.758
  1.478   1.31       180.064    Glucose                                                      0.005      −3.408
  1.698   5.34       448.1027   Naringenin-4′-*O*-β-[d]{.smallcaps}-Glucuronide              0.000      +3.061
  1.339   5.21       670.1768   Limocitrin 3,7-diglucoside                                   0.015      +2.829
  1.480   4.48       176.0687   2-Isopropylmaleate                                           0.005      +2.556
  1.245   1.11       668.1634   Euphorbianin                                                 0.027      +2.481
  1.634   4.91       180.0438   Caffeic Acid                                                 0.001      +2.355
  1.235   5.79       490.1128   Cyanidin 3-(6-acetylgalactoside)                             0.029      +2.216
  1.716   4.58       192.0629   Quinic acid                                                  0.000      +1.921
  1.515   5.58       207.0886   *N*-Acetyl-[l]{.smallcaps}-phenylalanine                     0.003      −1.786
  1.587   4.95       354.0962   Chlorogenic Acid                                             0.002      1.717
  1.608   8.12       492.1279   Malvidin 3-*O*-glucoside                                     0.001      −0.310
  1.369   5.69       168.042    Vanillic acid                                                0.012      −0.247
  1.369   6.30       272.0687   Naringeninchalcone                                           0.012      −0.247
  1.369   9.73       356.1271   Laurifolin                                                   0.012      −0.247
  1.369   5.78       534.1009   Cyanidin 3-*O*-(6-*O*-malonyl-β-[d]{.smallcaps}-glucoside)   0.012      −0.247
  1.369   5.23       535.1341   Malvidin 3-(6-acetylglucoside)                               0.012      −0.247
  1.369   6.31       558.1173   Dihydromorelloflavone                                        0.012      −0.247
  1.369   6.97       754.1943   Luteolin 7-glucuronide-3′,4′-dirhamnoside                    0.012      −0.247
  1.369   8.24       784.1795   Apigenin 7-Glucosyl-(1-\>2)-glucuronide-4′-glucuronide       0.012      −0.247

\* 0 day and 2 days is the logarithm of the ratio of the value of value (base 2), "+" means 2 days increase relative to 0 day, "−" means decrease. VIP: Variable Importance in the Projection; RT: retention time.

molecules-21-01648-t003_Table 3

###### 

The main identification obtained between 2 days and 3 days in ESI+ (*p* \< 0.05).

  VIP     RT (min)   Mass       Name                                                         *T*-Test   Fold (3/2) \*
  ------- ---------- ---------- ------------------------------------------------------------ ---------- ---------------
  1.482   10.60      354.2777   MG (18:2)                                                    0.023      −3.108
  1.333   6.11       534.1018   Cyanidin 3-*O*-(6-*O*-malonyl-β-[d]{.smallcaps}-glucoside)   0.010      +2.596
  1.081   1.04       174.0166   Aconitic acid                                                0.007      −2.281
  1.037   5.95       374.0975   Dihydroxy-6,7,4′,5′-tetramethoxyflavone                      0.022      +2.078
  1.656   6.34       316.0954   Dihydroxy-dimethoxyflavanone                                 0.018      +0.879
  1.449   0.82       115.064    Proline                                                      0.019      −0.282

\* 2 days and 3 days is the logarithm of the ratio of the value of value (base 2), "+" means 3 days increases relative to 2 days, "−" means decrease. VIP: Variable Importance in the Projection; RT: retention time.

molecules-21-01648-t004_Table 4

###### 

The main identification obtained between 2 days and 3 days in ESI− (*p* \< 0.05).

  VIP     RT (min)   Mass       Name                                                         *T*-Test   Fold (3/2) \*
  ------- ---------- ---------- ------------------------------------------------------------ ---------- ---------------
  1.289   4.578      192.0634   Quinic acid                                                  0.019      +25.997
  1.558   3.970      191.0619   *N*-Acetyl-[dl]{.smallcaps}-methionine                       0.002      +25.741
  1.810   6.100      448.1022   Naringenin-4′-*O*-β-[d]{.smallcaps}-Glucuronide              0.000      +24.727
  1.830   5.969      332.0543   Quercetagetin-methyl ether                                   0.000      +24.325
  1.295   9.730      356.1271   Laurifolin                                                   0.018      +23.249
  1.739   5.783      534.1009   Luteolin 5-(6″-malonylglucoside)                             0.000      +22.968
  1.588   5.234      535.1341   Malvidin 3-(6-acetylglucoside)                               0.001      +22.258
  1.264   5.144      358.068    Dihydroxy-dimethoxy-methylenedioxy                           0.022      +21.350
  1.200   7.953      610.0885   Gallocatechin 7,4′-di-*O*-gallate                            0.032      +21.183
  1.361   10.026     475.271    PE (18:3)                                                    0.011      +21.183
  1.779   5.245      318.0388   Myricetin                                                    0.000      +6.475
  1.254   11.404     532.1541   Flavonol 3-*O*-[d]{.smallcaps}-xylosylglucoside              0.023      +5.586
  1.422   5.464      534.0963   Cyanidin 3-*O*-(6-*O*-malonyl-β-[d]{.smallcaps}-glucoside)   0.007      +4.072
  1.737   5.877      218.1155   Pantothenic Acid                                             0.000      +3.618
  1.757   7.131      302.0438   Quercetin                                                    0.000      +3.545
  1.323   8.530      286.0838   Naringenin 5-methyl ether                                    0.015      +3.037
  1.606   4.247      304.0591   Pentahydroxyflavanone                                        0.001      +2.656
  1.342   6.523      476.1319   Naringenin 7-*O*-beta-[d]{.smallcaps}-glucoside 6″-acetate   0.013      +2.508
  1.399   5.708      450.1176   Eriodictyol-*O*-glucoside                                    0.008      +2.388
  1.577   1.056      176.0325   Ascorbic acid                                                0.001      −2.228
  1.395   13.135     278.2251   Linolenic Acid                                               0.009      +1.268
  1.123   5.787      490.1128   Cyanidin 3-(6-acetylgalactoside)                             0.049      +1.194
  1.338   4.912      180.0438   Caffeic Acid                                                 0.013      −1.091
  1.312   0.721      422.0835   Sucrose-6-phosphate                                          0.016      −0.608

\* 2 days and 3 days is the logarithm of the ratio of the value of value (base 2), "+" means 3 days increases relative to 2 days, "−" means decrease. VIP: Variable Importance in the Projection; RT: retention time.

molecules-21-01648-t005_Table 5

###### 

The main identification obtained between 3 days and 4 days in ESI+ (*p* \< 0.05).

  VIP     RT (min)   Mass       Name                                *T*-Test   Fold (4/3) \*
  ------- ---------- ---------- ----------------------------------- ---------- ---------------
  1.383   7.64       300.064    Trihydroxy-3-methoxyflavone         0.010      −3.618
  1.039   6.34       316.0954   Dihydroxy-7,2′-dimethoxyflavanone   0.000      +1.796
  1.155   10.43      354.2779   MG (18:2)                           0.037      −1.697
  1.899   11.12      356.2934   MG (18:1)                           0.036      −1.169
  1.333   4.02       117.0579   Indole                              0.010      +0.508
  2.041   10.39      198.1623   Lauroleic acid                      0.029      +0.304

\* 3 days and 4 days is the logarithm of the ratio of the value of value (base 2), "+" means 4 days increases relative to 3 days, "−" means decrease. VIP: Variable Importance in the Projection; RT: retention time.

molecules-21-01648-t006_Table 6

###### 

The main identification obtained between 3 days and 4 days in ESI− (*p* \< 0.05).

  VIP     RT (min)   Mass       Name                                                  *T*-Test   Fold (4/3) \*
  ------- ---------- ---------- ----------------------------------------------------- ---------- ---------------
  2.120   8.67       588.1278   Kolaflavanone                                         0.000      +5.933
  2.104   9.73       356.1271   Laurifolin                                            0.000      +3.667
  1.516   1.09       433.1176   Cyanidin 3-rhamnoside                                 0.034      +3.486
  1.579   1.32       216.040    2-*C*-Methyl-[d]{.smallcaps}-erythritol 4-phosphate   0.026      −3.477
  2.215   4.87       138.0319   Salicylic acid                                        0.000      +2.569
  1.871   5.50       302.0797   Ferreirin                                             0.004      +2.537
  1.518   0.68       250.153    Xanthoxin                                             0.034      −2.407
  2.173   7.52       316.0956   Eriodictyol 7,3′-dimethyl ether                       0.000      +2.239
  2.241   5.69       168.042    Vanillic acid                                         0.000      +2.192
  1.664   7.95       610.0885   Epigallocatechin 5,7-di-*O*-gallate                   0.017      +2.162
  2.028   5.14       358.068    Dihydroxy-dimethoxy-methylenedioxy                    0.001      +1.843
  2.096   3.97       191.0619   *N*-Acetyl-[dl]{.smallcaps}-methionine                0.001      +1.830
  1.554   4.97       450.1182   Eriodictyol 6-*O*-glucoside                           0.029      +1.777
  1.878   5.48       448.1021   Naringenin 5-*O*-glucuronide                          0.004      +1.723
  1.765   7.94       316.0593   Quercetin 3-methyl ether                              0.009      +1.717
  1.565   5.82       288.0642   Eriodictyol                                           0.027      +1.613
  1.683   8.53       286.0838   Naringenin 5-methyl ether                             0.015      +1.450
  1.621   6.60       136.0522   Phenylacetic acid                                     0.021      −1.387
  2.032   5.25       318.0388   Myricetin                                             0.001      +1.256
  1.784   4.58       192.0634   Quinic acid                                           0.008      +1.190
  1.640   13.13      278.2251   Linolenic Acid                                        0.019      −1.021

\* 3 days and 4 days is the logarithm of the ratio of the value of value (base 2), "+" means 4 days increases relative to 3 days, "−" means decrease. VIP: Variable Importance in the Projection; RT: retention time.

molecules-21-01648-t007_Table 7

###### 

The main identification obtained between 4 days and 5 days in ESI+ (*p* \< 0.05).

  VIP     RT (min)   Mass       Name                                 *T*-Test   Fold (5/4) \*
  ------- ---------- ---------- ------------------------------------ ---------- ---------------
  1.222   11.44      315.278    Dehydrophytosphingosine              0.023      +22.358
  1.547   13.14      278.2252   Linolenic Acid                       0.000      +2.291
  1.106   10.43      354.2779   MG(18:2)                             0.017      +1.874
  1.337   6.98       708.189    Patuletin 3,7-(3-acetylrhamnoside)   0.004      +1.359
  1.110   7.64       300.064    Trihydroxy-3-methoxyflavone          0.032      +1.167
  1.317   0.66       155.0697   Histidine                            0.003      -0.467

\* 4 days and 5 days is the logarithm of the ratio of the value of value (base 2), "+" means 5 days increases relative to 4 days, "−" means decrease. VIP: Variable Importance in the Projection; RT: retention time.

molecules-21-01648-t008_Table 8

###### 

The main identification obtained between 4 days and 5 days in ESI− (*p* \< 0.05).

  VIP     RT (min)   Mass       Name                                              *T*-Test   Fold (5/4) \*
  ------- ---------- ---------- ------------------------------------------------- ---------- ---------------
  1.442   6.18       448.1026   Naringenin-4′-*O*-β-[d]{.smallcaps}-Glucuronide   0.015      −23.434
  1.259   1.06       176.0325   Ascorbic acid                                     0.042      −3.930
  1.828   4.39       130.063    Ketoleucine                                       0.000      +2.189
  1.840   13.13      278.2251   Linolenic Acid                                    0.000      +2.116
  1.640   7.07       264.1366   Abscisic Acid                                     0.003      +2.097
  1.954   5.23       535.1341   Malvidin 3-(6-acetylglucoside)                    0.000      +2.016
  1.503   5.21       670.1768   Limocitrin 3,7-diglucoside                        0.010      +1.913
  1.515   4.78       122.0368   Salicylaldehyde                                   0.009      −1.547
  1.436   13.73      280.2405   Linoleic acid                                     0.016      1.395
  1.694   1.34       131.0952   Leucine                                           0.002      −1.374
  1.580   7.90       302.0799   Ferreirin                                         0.005      +1.275
  1.238   3.96       354.0963   Chlorogenic Acid                                  0.046      −1.241
  1.228   6.74       270.0534   Trihydroxyflavone                                 0.048      −1.213
  1.843   5.69       168.042    Vanillic acid                                     0.000      +1.072
  1.807   0.69       155.0699   Histidine                                         0.000      −0.979
  1.951   2.22       148.0526   Cinnamic acid                                     0.000      −0.827
  1.280   9.73       356.1271   Laurifolin                                        0.038      +0.821
  1.476   4.58       376.0789   Tetrahydroxy-3,6,2′-trimethoxyflavone             0.012      −0.815
  1.259   8.67       588.1278   Kolaflavanone                                     0.042      +0.763
  1.352   5.89       194.0581   ferulic acid                                      0.026      −0.639
  1.543   4.01       117.0581   Indole                                            0.007      −0.609
  1.493   0.74       147.0545   Glutamate                                         0.011      −0.503
  1.610   4.58       422.0842   Sucrose-6-phosphate                               0.004      −0.513

\* 4 days and 5 days is the logarithm of the ratio of the value of value (base 2), "+" means 5 days increases relative to 4 days, "−" means decrease. VIP: Variable Importance in the Projection; RT: retention time.
